The Pennant Group, Inc.

PNTG Healthcare Medical Care Facilities

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.

Revenue
+32.0%
EPS
+55.6%
Free cash flow
−3.19%
Total debt
+662.8%

Quarter to September 2026, against a year earlier

37.02 2.98 −7.45%
Market cap
$1.4B
P/E
37.3×
Fwd P/E
36.7×
Dividend yield
—
F-score
5/9
Altman Z
2.29
Beneish M
−2.52
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Sep '26 From the 10-Q filed 4 Nov Jun '26 Mar '26 Dec '25 Older periods
Revenue
1,174.92 1,101.71 1,023.23 947.71

+8 more TTM periods

Gross Profit
161.12 152.34 140.72 130.50
Operating Income
68.47 62.20 56.54 51.89
EBT
57.39 52.60 48.34 45.63
Income after Tax
42.64 38.45 35.54 33.76
Net Income Common
35.88 32.32 30.32 29.58
EPS (Diluted)
0.99 0.90 0.85 0.83
Shares (Diluted, Weighted)
35.85 35.58 35.43 35.29
Gross Margin
13.71% 13.83% 13.75% 13.77%
EBIT Margin
5.83% 5.65% 5.53% 5.47%
Net Profit Margin
3.05% 2.93% 2.96% 3.12%
Free Cash Flow Margin
2.92% 3.15% 4.96% 3.83%
EBITDA
81.38 73.40 66.77 61.31
EBIT
68.47 62.20 56.54 51.89

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 4 Nov 2026